Jump to navigation
The Pharmacy and Therapeutics (P&T) Committee is an advisory board established pursuant to Executive Order D004-07. The committee performs clinical reviews of drug classes and makes recommendations which help the Department develop and manage the Medicaid Preferred Drug List (PDL).
The P&T Committee is required to consider clinical criteria such as drug safety and efficacy when making its recommendations. The committee also considers public comments and testimony related to the drug classes being reviewed or other PDL-related agenda items.
Our meeting has a new location: 303 E. 17th Ave, Denver, Colorado 80203
1:00 p.m. - 5:00 p.m.
The Board meets once quarterly in January, April, July, and October
MEETING WILL TAKE PLACE ON THE 7TH FLOOR IN CONFERENCE ROOMS 7ABC
MEETING WILL TAKE PLACE ON THE 11TH FLOOR IN CONFERENCE ROOMS 11ABC
Our meeting has a new location: 303 E. 17th Ave, 7th Floor Conference Room, 7ABC, Denver, Colorado 80203
***11th Floor Conference Room, 11ABC***
The P&T Committee consists of 7 physicians, 4 pharmacists and 2 client representatives, who are appointed by the Department's Executive Director. Review the Policies and Procedures Manual for more information on the committee's membership, duties and policies.
January 2018 - December 2019 Term
Lynn Parry, MD (Chairperson)
Gwen Black, PharmD
Marisa Wiktor, MD
Kelet Robinson, MD
Thuy McKitrick, PharmD
Jed Ward
January 2019 - December 2020 Term
Andrew Davis, PharmD
James Feinstein, MD
Kimberley Jackson, DO (Vice-Chairperson)
Steven Russell, MD
David Elwell, MD
Morgan Payne, PharmD
Dan Severn, DO
Reasonable accommodations for the meetings will be provided upon request for persons with disabilities. Please contact the Program Administrator at least one week prior to the scheduled meeting if you need special arrangements.
